Eli Lilly And Company (India ) Private Limited, a active private limited company, was established on 18 March 1993 in Haryana, Haryana, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U24239HR1993PTC034844. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹22.93 Cr.
It upholds a compliant status. Its leadership includes Rakesh Upadhyay (Whole-Time Director), Abha Mahalka (Director), Manish Thakorlal Mistry (Director). Past directors included Deepak Arora, Sandeep Gupta, Melt Van Der Spuy. It holds no open charges and ₹13.32 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No-92Sector 32 Gurgaon, Haryana, Haryana, 122001.
U24239HR1993PTC034844
034844
18 March 1993
₹40.00 Cr
₹22.93 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Eli Lilly And Company (India ) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakesh Upadhyay | Whole-Time Director | 11 Dec 2019 | Current |
| Abha Mahalka | Director | 30 Jan 2024 | Current |
| Manish Thakorlal Mistry | Director | 26 Jun 2024 | Current |
| Yusuf Bilal Birinc | Whole-Time Director | 25 Oct 2021 | Current |
| Shilpa Gupta | Additional Director | 05 Jun 2025 | Current |
| Winselow S Tucker Jr | Additional Director | 18 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 24 Jul 2019 | Past |
| Pramod Abcsdd | Managing Director | 03 Nov 2011 | Past |
| Pramod Abcsdd | Managing Director | 31 Aug 2013 | Past |
| Pramod Abcsdd | Whole-Time Director | 10 Feb 2017 | Past |
| Pramod Abcsdd | Whole-Time Director | 20 Nov 2019 | Past |
| Pramod Abcsdd | Director | 29 Feb 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eli Lilly And Company (India ) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.22% increase. The company also saw a slight decrease in profitability, with a 8.21% decrease in profit. The company's net worth Soared by an impressive increase of 10.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Eli Lilly And Company (India ) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹133,249,014.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Oct 2016 | Hdfc Bank Limited | ₹1.37 M | Satisfied |
| 15 Oct 2016 | Hdfc Bank Limited | ₹0.75 M | Satisfied |
| 01 Oct 2016 | Hdfc Bank Limited | ₹0.93 M | Satisfied |
| 08 Sep 2016 | Hdfc Bank Limited | ₹1.21 M | Satisfied |
| 30 Jul 2016 | Hdfc Bank Limited | ₹0.90 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Eli Lilly And Company (India ), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Eli Lilly And Company (India ), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eli Lilly And Company (India )'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nitasha Ghai was appointed as a Company Secretary was appointed as a Company Secretary on 16 Oct 2025 & has been associated with this company since 1 month 16 days . was documented.
Eli Lilly And Company (India ) Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Winselow S Tucker Jr was appointed as a Additional Director was appointed as a Additional Director on 18 Aug 2025 & has been associated with this company since 3 months 16 days . was completed.
The activity Shilpa Gupta was appointed as a Additional Director was appointed as a Additional Director on 05 Jun 2025 & has been associated with this company since 5 months 29 days . was completed.
Eli Lilly And Company (India ) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
The activity Manish Thakorlal Mistry was appointed as a Director was appointed as a Director on 26 Jun 2024 & has been associated with this company since 1 year 5 months . was completed.
Veri odaklı sağlık girişimi Zephyr AI, 111 milyon dolar yatırım aldı. ABD merkezli şirketin A serisi yatırım turunda Revolution Growth, Eli Lilly & Company, Jeff Skoll ve EPIQ Capital Group yer aldı. Zephyr AI yeni yatırımı, hastalık türlerinin daha iyi anlaşılması ve yeni tedavi yöntemlerinin geliştirilmesi için kullanılacağını açıkladı. Zephyr AI, 2020 yılında Jeff Sherman ve Grant Verstandig tarafında faaliyete geçti. Şirket, yapay zeka teknolojilerini kullanarak….
Me: I'm a biopharmaceutical company making good stuff. HKEX: Wow, impressive. #InnoventBiologics #HighQuality #MakingMoves.
The CIN of Eli Lilly And Company (India ) Private Limited is U24239HR1993PTC034844.
Eli Lilly And Company (India ) Private Limited is headquartered at Plot No-92Sector 32 Gurgaon, Haryana, Haryana, 122001.
Eli Lilly And Company (India ) Private Limited was incorporated on 18 March 1993.
The current directors of Eli Lilly And Company (India ) Private Limited are
The primary industry of Eli Lilly And Company (India ) Private Limited is Hospital And Medical Care.
Eli Lilly And Company (India ) Private Limited is unlisted.
The authorized capital of Eli Lilly And Company (India ) Private Limited is ₹40.00 Cr, and the paid-up capital is ₹22.93 Cr.
The compliance status of Eli Lilly And Company (India ) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX